Physician profile
Frederick B Thompson
NPI 1912919770
$1,621.46
in general payments reported to CMS, 2019-2025
26 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $117 · 2022: $192 · 2023: $531 · 2024: $192 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $243.63 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $214.14 | 2022-2025 | Slynd |
| Pfizer INC. | $148.69 | 2022-2025 | |
| Daiichi Sankyo INC. | $143.94 | 2019-2025 | Injectafer |
| Sage Therapeutics, LLC | $102.31 | 2024-2025 | Zurzuvae |
| Novo Nordisk INC | $85.44 | 2019-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $75.29 | 2025 | |
| Covidien LP | $72.18 | 2020 | |
| Exact Sciences Corporation | $72.08 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $66.64 | 2019-2023 | |
| Astellas Pharma US INC | $52.15 | 2023-2025 | Veozah |
| Medtronic, INC. | $46.62 | 2023 | Ligasure |
| Organon LLC | $45.71 | 2024-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $36.76 | 2025 | Myfembree |
| Coopersurgical, INC. | $32.66 | 2019-2024 | Paragard T 380a |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $31.46 | 2023 | |
| Alexion Pharmaceuticals, INC. | $17.90 | 2019 | |
| Bard Access Systems, INC. | $17.89 | 2019 | |
| Agile Therapeutics, INC. | $17.28 | 2023 | Twirla |
| Therapeuticsmd, INC. | $16.83 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.68 | 2022 | |
| Avanos Medical | $16.37 | 2023 | On-Q* Pump and Accessories |
| Mallinckrodt Hospital Products INC. | $13.95 | 2020 | |
| Scynexis, INC. | $13.30 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.46 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.